121 related articles for article (PubMed ID: 16557218)
1. Combination therapy with tranilast and angiotensin-converting enzyme inhibition provides additional renoprotection in the remnant kidney model.
Kelly DJ; Zhang Y; Cox AJ; Gilbert RE
Kidney Int; 2006 Jun; 69(11):1954-60. PubMed ID: 16557218
[TBL] [Abstract][Full Text] [Related]
2. Passive Heymann nephritis: evidence that angiotensin-converting enzyme inhibition reduces proteinuria and retards renal structural injury.
Zoja C; Corna D; Bruzzi I; Foglieni C; Bertani T; Remuzzi G; Benigni A
Exp Nephrol; 1996; 4(4):213-21. PubMed ID: 8983642
[TBL] [Abstract][Full Text] [Related]
3. Blockade of the renin-angiotensin and endothelin systems on progressive renal injury.
Cao Z; Cooper ME; Wu LL; Cox AJ; Jandeleit-Dahm K; Kelly DJ; Gilbert RE
Hypertension; 2000 Oct; 36(4):561-8. PubMed ID: 11040236
[TBL] [Abstract][Full Text] [Related]
4. Tranilast attenuates structural and functional aspects of renal injury in the remnant kidney model.
Kelly DJ; Zhang Y; Gow R; Gilbert RE
J Am Soc Nephrol; 2004 Oct; 15(10):2619-29. PubMed ID: 15466266
[TBL] [Abstract][Full Text] [Related]
5. Long-term protection of obese Zucker rat kidneys from fibrosis and renal failure with an angiotensin-converting enzyme inhibitor/diuretic combination.
Renaud IM; Chainey A; Belair MF; Mandet C; Michel O; Myara I; Chevalier J; Plante GE
Fundam Clin Pharmacol; 2004 Aug; 18(4):437-47. PubMed ID: 15312150
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-beta in human diabetic nephropathy: effects of ACE inhibition.
Langham RG; Kelly DJ; Gow RM; Zhang Y; Cordonnier DJ; Pinel N; Zaoui P; Gilbert RE
Diabetes Care; 2006 Dec; 29(12):2670-5. PubMed ID: 17130203
[TBL] [Abstract][Full Text] [Related]
7. Adding a statin to a combination of ACE inhibitor and ARB normalizes proteinuria in experimental diabetes, which translates into full renoprotection.
Zoja C; Corna D; Gagliardini E; Conti S; Arnaboldi L; Benigni A; Remuzzi G
Am J Physiol Renal Physiol; 2010 Nov; 299(5):F1203-11. PubMed ID: 20719975
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of left ventricular fibrosis by tranilast in rats with renovascular hypertension.
Hocher B; Godes M; Olivier J; Weil J; Eschenhagen T; Slowinski T; Neumayer HH; Bauer C; Paul M; Pinto YM
J Hypertens; 2002 Apr; 20(4):745-51. PubMed ID: 11910312
[TBL] [Abstract][Full Text] [Related]
9. Superior renoprotective effects of combination therapy with ACE and AGE inhibition in the diabetic spontaneously hypertensive rat.
Davis BJ; Forbes JM; Thomas MC; Jerums G; Burns WC; Kawachi H; Allen TJ; Cooper ME
Diabetologia; 2004 Jan; 47(1):89-97. PubMed ID: 14647892
[TBL] [Abstract][Full Text] [Related]
10. Increased renoprotection with ACE inhibitor plus aldosterone antagonist as compared to monotherapies--the effect on podocytes.
Nemeth Z; Kokeny G; Godo M; Mózes M; Rosivall L; Gross ML; Ritz E; Hamar P
Nephrol Dial Transplant; 2009 Dec; 24(12):3640-51. PubMed ID: 19666910
[TBL] [Abstract][Full Text] [Related]
11. Functional and partial morphological regression of established renal injury in the obese zucker rat by blockade of the renin-angiotensin system.
Sebeková K; Lill M; Boor P; Heidland A; Amann K
Am J Nephrol; 2009; 29(3):164-70. PubMed ID: 18753741
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor expression and glomerular endothelial cell loss in the remnant kidney model.
Kelly DJ; Hepper C; Wu LL; Cox AJ; Gilbert RE
Nephrol Dial Transplant; 2003 Jul; 18(7):1286-92. PubMed ID: 12808163
[TBL] [Abstract][Full Text] [Related]
13. [Molecular mechanisms of nephro-protective action of enalapril in experimental chronic renal failure].
Ciechanowicz A
Ann Acad Med Stetin; 1999; Suppl 52():1-93. PubMed ID: 10589103
[TBL] [Abstract][Full Text] [Related]
14. Dual blockade of the renin-angiotensin-aldosterone system with high-dose angiotensin-converting enzyme inhibitor for nephroprotection: an open, controlled, randomized study.
Tylicki L; Renke M; Rutkowski P; Larczyński W; Aleksandrowicz E; Lysiak-Szydlowska W; Rutkowski B
Scand J Urol Nephrol; 2008; 42(4):381-8. PubMed ID: 19230172
[TBL] [Abstract][Full Text] [Related]
15. V1/V2 Vasopressin receptor antagonism potentiates the renoprotection of renin-angiotensin system inhibition in rats with renal mass reduction.
Perico N; Zoja C; Corna D; Rottoli D; Gaspari F; Haskell L; Remuzzi G
Kidney Int; 2009 Nov; 76(9):960-7. PubMed ID: 19625993
[TBL] [Abstract][Full Text] [Related]
16. Resveratrol is equipotent to perindopril in attenuating post-infarct cardiac remodeling and contractile dysfunction in rats.
Raj P; Aloud BM; Louis XL; Yu L; Zieroth S; Netticadan T
J Nutr Biochem; 2016 Feb; 28():155-63. PubMed ID: 26878793
[TBL] [Abstract][Full Text] [Related]
17. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
Vogt L; Kocks MJ; Laverman GD; Navis G
Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
[TBL] [Abstract][Full Text] [Related]
18. Chronic kidney disease: cardiac and renal angiotensin-converting enzyme (ACE) 2 expression in rats after subtotal nephrectomy and the effect of ACE inhibition.
Burrell LM; Burchill L; Dean RG; Griggs K; Patel SK; Velkoska E
Exp Physiol; 2012 Apr; 97(4):477-85. PubMed ID: 22198016
[TBL] [Abstract][Full Text] [Related]
19. Aliskiren and perindopril reduce the levels of transforming growth factor-β in patients with non-diabetic kidney disease.
Lizakowski S; Tylicki L; Renke M; Rutkowski P; Heleniak Z; Sławińska-Morawska M; Aleksandrowicz-Wrona E; Małgorzewicz S; Rutkowski B
Am J Hypertens; 2012 Jun; 25(6):636-9. PubMed ID: 22357413
[TBL] [Abstract][Full Text] [Related]
20. Renal amylin binding in normotensive and hypertensive rats: effects of angiotensin converting enzyme inhibition with perindopril.
Cao Z; Wookey PJ; Wu LL; Voskuil M; van Geenen RC; Cooper ME
J Hypertens; 1997 Nov; 15(11):1245-52. PubMed ID: 9383173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
